PUBLICATION

Encapsulation of a TRPM8 Agonist, WS12, in Lipid Nanocapsules Potentiates PC3 Prostate Cancer Cell Migration Inhibition through Channel Activation

Authors
Grolez, G.P., Hammadi, M., Barras, A., Gordienko, D., Slomianny, C., Völkel, P., Angrand, P.O., Pinault, M., Guimaraes, C., Potier-Cartereau, M., Prevarskaya, N., Boukherroub, R., Gkika, D.
ID
ZDB-PUB-190530-3
Date
2019
Source
Scientific Reports   9: 7926 (Journal)
Registered Authors
Angrand, Pierre-Olivier, Völkel, Pamela
Keywords
none
MeSH Terms
  • Anilides/administration & dosage
  • Anilides/pharmacology*
  • Cell Migration Inhibition/drug effects*
  • Humans
  • Lipids/chemistry
  • Male
  • Menthol/administration & dosage
  • Menthol/analogs & derivatives*
  • Menthol/pharmacology
  • Nanocapsules/chemistry
  • PC-3 Cells
  • Prostatic Neoplasms/drug therapy*
  • Prostatic Neoplasms/metabolism
  • TRPM Cation Channels/agonists*
  • TRPM Cation Channels/metabolism
PubMed
31138874 Full text @ Sci. Rep.
Abstract
In prostate carcinogenesis, expression and/or activation of the Transient Receptor Potential Melastatin 8 channel (TRPM8) was shown to block in vitro Prostate Cancer (PCa) cell migration. Because of their localization at the plasma membrane, ion channels, such as TRPM8 and other membrane receptors, are promising pharmacological targets. The aim of this study was thus to use nanocarriers encapsulating a TRPM8 agonist to efficiently activate the channel and therefore arrest PCa cell migration. To achieve this goal, the most efficient TRPM8 agonist, WS12, was encapsulated into Lipid NanoCapsules (LNC). The effect of the nanocarriers on channel activity and cellular physiological processes, such as cell viability and migration, were evaluated in vitro and in vivo. These results provide a proof-of-concept support for using TRPM8 channel-targeting nanotechnologies based on LNC to develop more effective methods inhibiting PCa cell migration in zebrafish xenograft.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping